A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among patients with established coronary artery disease. Mitsuhiro Yokoyama of Kobe University told us more about it.
[audio:https://www.audiomedica.com/podcasting/aha2005/Mitsuhiro_Yokoyama.mp3]
Audio Journal of Cardiovascular Medicine: September 6th 2006 6 Sep, 2006 Withholding Abciximab Infusion After Stenting 17 Nov, 2005 
SAVOR-TIMI 53 study: saxagliptin had better glucose control than placebo but no cardiovascular benefit 22 Sep, 2013 Europe Leaps to Action on Heart-Unfriendly Lifestyles 12 Sep, 2005 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014